Thiamine Metabolites and Dementia?  by Kuller, Lewis H.
EBioMedicine 3 (2016) 14
Contents lists available at ScienceDirect
EBioMedicine
j ourna l homepage: www.eb iomed ic ine.comCommentaryThiamine Metabolites and Dementia?Lewis H. Kuller ⁎
Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA 15213, United StatesDOI of original article: http://dx.doi.org/10.1016/j.ebi
⁎ Department of Epidemiology, Graduate School o
Pittsburgh, 130 North Belleﬁeld Avenue, Room 550, Pittsb
E-mail address: kullerl@edc.pitt.edu.
http://dx.doi.org/10.1016/j.ebiom.2015.11.044
2352-3964/© 2015 The Author. Published by Elsevier B.Va r t i c l e i n f o An alternative hypothesis is that lower thiamine metabolites inArticle history:
Received 25 November 2015
Accepted 25 November 2015
Available online 26 November 2015
patients with AD identiﬁed in the paper by Xiaoli Pan and colleagues
in EBioMedicine (Pan et al., 2015) is due to changes in patients' diet
after diagnosis of dementia or secondary to comorbidity after diagnosis
of dementia, e.g. reverse causality.
The next stepswould be to compare blood levels of thiaminemetab-
olites in longitudinal studies with available stored blood samples priorThe determinants of amyloid deposition in the brain, increased
increased in relation to thiamine metabolites independent of age and
education, then small feeding experiments in humans could evaluateintracerebral phosphorylated tau, hippocampal atrophy, and loss of syn-
apses in areas of brain (the pathogenic determinants ofmost dementia)
remain undetermined except for Mendelian genetic disorders and
higher risk of both amyloid deposition and dementia among individuals
who carry the apolipoprotein ε4 (APOE ε4) genotype, especially homo-
zygous ε4 (Kuller et al., in press; Vardarajan et al., 2014; Leduc et al.,
2010).
The incidence of dementia doubles every 5 years after the age of 65
and probably 2/3 or more of incident dementia cases occur over the age
of 80 (Prince et al., 2013). The increasing longevity of the population is a
major determinant of the ‘epidemic of dementia’ in many countries.
There is little evidence that Alzheimer's disease (AD) pathology or inci-
dence of dementia varies substantially among countries or within coun-
tries. Better-educated individuals and those with higher IQ have lower
age-speciﬁc incidence of dementia attributed to ‘brain reserve.’ An ex-
cess or restriction of an exposure in the environment, lifestyle, such as
consumption of a nutrient like thiamine, could be a determinant of in-
creased or decreased risk of an age-associated disease like dementia,
speciﬁcally AD. The brain requirement of a speciﬁc nutrient, e.g. thia-
mine, could increase with aging, either due to loss of a cellular receptor
or changes in intracellular metabolism, greater degradation of the me-
tabolite or increase in interfering agents, e.g. drugs.
A vitamin deﬁciency in the past, e.g. pellagra, was a ‘cause of demen-
tia’ that was successfully treated by diet change well before the speciﬁc
vitamin was identiﬁed (nicotinic acid) (Terris, 1964). There is no evi-
dence at present that deﬁciency of thiamine or any other B vitamin de-
creases risk of dementia. However, it could be necessary to consume a
speciﬁcmetabolite of the vitamin to have a beneﬁcial effect in the brain.om.2015.11.039.
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. This is an open access article underto diagnosis of dementia. If the relative risk of AD or dementia is
whether thiaminemetabolites have any effect on cognition in cognitive-
ly normal, mild cognitive impairment (MCI), and dementia patients and
ﬁnally test the hypothesis by feeding metabolites in larger clinical trials
of both risk of dementia among those who are cognitively normal and
effects on changes in cognition in MCI and possibly dementia patients.
The search for a nutrient that could prevent or delay onset or even
reverse pathology of AD or other pathologies associated with dementia
should have high priority given the worldwide magnitude of dementia,
growing incidence and prevalence, and lack of effective therapies for
prevention and treatment. It is very possible that a deﬁciency of a nutri-
ent could be a cause of dementia among older individuals, possibly the
nutrient is important only in susceptible individuals based on unique
genotype, older ages, or comorbidities.
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